Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 3
2014 1
2016 3
2017 3
2018 2
2019 3
2020 3
2021 7
2022 13
2023 15
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jia xiang huang[Author] (6 results)?
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity.
Liang J, Wang H, Ding W, Huang J, Zhou X, Wang H, Dong X, Li G, Chen E, Zhou F, Fan H, Xia J, Shen B, Cai D, Lan P, Jiang H, Ling J, Cheng Z, Liu X, Sun J. Liang J, et al. Among authors: huang j. Sci Adv. 2020 Aug 28;6(35):eabc3646. doi: 10.1126/sciadv.abc3646. eCollection 2020 Aug. Sci Adv. 2020. PMID: 32923651 Free PMC article.
miR-214 could promote myocardial fibrosis and cardiac mesenchymal transition in VMC mice through regulation of the p53 or PTEN-PI3K-Akt signali pathway, promoting CF proliferation and inhibiting its ng pathway.
Huang X, Zheng D, Liu C, Huang J, Chen X, Zhong J, Wang J, Lin X, Zhao C, Chen M, Su S, Chen Y, Xu C, Lin C, Huang Y, Zhang S. Huang X, et al. Among authors: huang j. Int Immunopharmacol. 2023 Nov;124(Pt A):110765. doi: 10.1016/j.intimp.2023.110765. Epub 2023 Aug 28. Int Immunopharmacol. 2023. PMID: 37647681
Therapeutic potential of ADSC-EV-derived lncRNA DLEU2: A novel molecular pathway in alleviating sepsis-induced lung injury via the miR-106a-5p/LXN axis.
He W, Xu C, Huang Y, Zhang Q, Chen W, Zhao C, Chen Y, Zheng D, XinyueLin, Luo Q, Chen X, Zhang Z, Wu X, Huang J, Lin C, Huang Y, Zhang S. He W, et al. Among authors: huang j. Int Immunopharmacol. 2024 Mar 30;130:111519. doi: 10.1016/j.intimp.2024.111519. Epub 2024 Mar 4. Int Immunopharmacol. 2024. PMID: 38442573
47 results